Stockreport

VYNE Therapeutics (NASDAQ:VYNE) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]

VYNE Therapeutics Inc.  (VYNE) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk tha [Read more]